Tarsus Pharmaceuticals (TARS) Gross Profit (QoQ) (2021 - 2026)
Tarsus Pharmaceuticals (TARS) Gross Profit (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn |
| 10 | Tarsus Pharmaceuticals | 2.61 Bn | 2.51 Bn | 152.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.47% |
| Dec 31, 2025 | 27.50% |
| Sep 30, 2025 | 14.48% |
| Jun 30, 2025 | 31.86% |
| Mar 31, 2025 | 18.94% |
| Dec 31, 2024 | 37.00% |
| Sep 30, 2024 | 18.69% |
| Jun 30, 2024 | 45.64% |
| Mar 31, 2024 | 118.89% |
| Dec 31, 2023 | 693.84% |
| Mar 31, 2023 | -73.96% |
| Jun 30, 2022 | 2,816.01% |
| Mar 31, 2022 | 39.78% |
| Dec 31, 2021 | -69.19% |
| Sep 30, 2021 | -94.48% |
| Jun 30, 2021 | -33.78% |